| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 62,723 | 67,869 | 66,305 | 70,048 | | Cost of Revenue | 47,628 | 50,762 | 52,157 | 54,817 | | | Gross Profit | 15,095 | 17,107 | 14,148 | 15,231 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 17,518 | 18,712 | 18,895 | 22,724 | | Non Recurring | 12,862 | 4,419 |
-
| 133,231 | | Others | 1,239 | 1,280 | 1,330 | 1,480 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (16,524) | (7,304) | (6,077) | (142,204) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (103) | (314) | (42) | (1,404) | | Earnings Before Interest And Taxes | (16,627) | (7,618) | (6,119) | (143,608) | | Interest Expense | 659 | 643 | 315 | (780) | | Income Before Tax | (17,286) | (8,261) | (6,434) | (142,828) | | Income Tax Expense | 47,393 | (1,807) | (2,638) | (47,550) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (64,679) | (6,454) | (3,796) | (95,278) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (64,679) | (6,454) | (3,796) | (95,278) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($64,679) | ($6,454) | ($3,796) | ($95,278) |
|
1.52% Nasdaq 0.00%
Income Statement
